Trapelo™ gives oncology practice leaders a single comprehensive module for: 1) precision medicine decision-support; 2) molecular test ordering and management; and 3) synthesized, actionable, evidence-supported reports that standardize results from all practice-preferred labs. This precision medicine platform, accessible from any EMR, methodizes molecular testing across the practice, helping all oncologists determine the appropriate use for precision medicines regardless of their prior experience. By optimizing the use of molecular testing, Trapelo reduces variability of care, improves practice outcomes, and drives efficiency.  

 

• Comprehensive: Effective for all solid tumors 

• Connected: Integrated with labs and payors

• Convenient: Evidence-supported molecular testing guidance, accessible from within your EMR